Literature DB >> 17097053

Differential serum proteomic analysis in a model of metabolic disease.

Takayoshi Matsumura1, Toru Suzuki, Nanae Kada, Kenichi Aizawa, Yoshiko Munemasa, Ryozo Nagai.   

Abstract

Protein profiling would aid in better understanding the pathophysiology of metabolic disease. Here, we report on differential proteomic analysis using an animal model of diabetes mellitus and associated metabolic disorders (Otsuka Long-Evans Tokushima Fatty rat). Serum was analyzed by a new two-dimensional liquid chromatography system which separated proteins by chromatofocusing and subsequent reversed-phase chromatography. This is the first application of this approach to differential serum proteomics. Differentially expressed proteins, identified with MALDI-TOF mass spectrometry, included apolipoproteins and alpha2-HS-glycoprotein. These findings add to our understanding of the underlying pathophysiology. This new proteomic analysis is a promising tool to elucidate disease mechanisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097053     DOI: 10.1016/j.bbrc.2006.10.137

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Regulation of transforming growth factor-beta-dependent cyclooxygenase-2 expression in fibroblasts.

Authors:  Takayoshi Matsumura; Toru Suzuki; Kenichi Aizawa; Daigo Sawaki; Yoshiko Munemasa; Junichi Ishida; Ryozo Nagai
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

2.  The application of post-translational modification oriented serum proteomics to assess experimental diabetes with complications.

Authors:  Han-Min Chen; Lin-Chien Lee; Kuang-Yu Hu; Wei-Jern Tsai; Cheng Huang; Hui-Jen Tsay; Hui-Kang Liu
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.